Immunome, Inc. (NASDAQ:IMNM – Get Free Report) gapped up prior to trading on Monday after an insider bought additional shares in the company. The stock had previously closed at $9.82, but opened at ...
Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...